Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients.
about
Circulating tumor cells in breast cancerDissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the HaystackClinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and BackCirculating tumor cells versus circulating tumor DNA in lung cancer-which one will win?TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancerA hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model.Functional studies on circulating and disseminated tumor cells in carcinoma patientsEffect of Cnidium Lactone on Serum Mutant P53 and BCL-2/BAX Expression in Human Prostate Cancer Cells PC-3 Tumor-Bearing BALB/C Nude Mouse ModelCirculating tumor cells in prostate cancer: Precision diagnosis and therapyNew applications of the acridine orange fluorescence staining method: Screening for circulating tumor cellsCritical issues in the clinical application of liquid biopsy in non-small cell lung cancer.Using PDX for Preclinical Cancer Drug Discovery: The Evolving Field.Liquid biopsy in pancreatic cancer: the beginning of a new era.
P2860
Q26774808-3005978E-757D-4BE9-AC3D-2F9F02FD8AAFQ28067549-9DD26A03-0D2E-4DD1-A1EF-928DE51058A8Q28070333-BB2C7517-85BF-471A-9731-8B0DCA0B57F0Q28077340-77906F65-34C3-4DE2-9020-F0A207926D8FQ35828584-EB3AA54D-16C0-485C-8E5C-8A1265431B2DQ37362844-9FAFF961-B93E-48B4-98E7-878948DEF0B7Q38723767-2D570EA0-624E-48FE-9C58-032DA5765FB5Q38842801-2EFD300A-8383-4CC0-8175-A55602D9CA32Q41142322-D9405195-A3F4-4483-8668-12DC14A92A9DQ42290651-465415E5-5723-44CC-8BB0-8208280E747CQ47104064-D16D1B1E-9CCB-48B9-B95F-A7B0419088AEQ55148658-7D40EE51-BC29-41DF-B9C6-8F520E3255D2Q55187959-75A353A0-454B-470B-BD52-507909B3FBFE
P2860
Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Retaining the long-survive cap ...... o of prostate cancer patients.
@ast
Retaining the long-survive cap ...... o of prostate cancer patients.
@en
Retaining the long-survive capacity of Circulating Tumor Cells
@nl
type
label
Retaining the long-survive cap ...... o of prostate cancer patients.
@ast
Retaining the long-survive cap ...... o of prostate cancer patients.
@en
Retaining the long-survive capacity of Circulating Tumor Cells
@nl
prefLabel
Retaining the long-survive cap ...... o of prostate cancer patients.
@ast
Retaining the long-survive cap ...... o of prostate cancer patients.
@en
Retaining the long-survive capacity of Circulating Tumor Cells
@nl
P2093
P2860
P50
P356
P1433
P1476
Retaining the long-survive cap ...... o of prostate cancer patients.
@en
P2093
Alberto Amadori
Antonella Facchinetti
Giorgia Nardo
Marco Pizzi
Maria Chiara Scaini
Mariangela Manicone
Massimo Rugge
Stefania De Faveri
Vito Barbieri
P2860
P356
10.18632/ONCOSCIENCE.8
P577
2013-12-31T00:00:00Z